Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Concomitant adult onset xanthogranuloma and IgG4-related orbital disease: a rare occurrence.

Orbit (Amsterdam, Netherlands)·2020

Same author

Improving Resident Performance in Oculoplastic Surgery: A New Curriculum Using Surgical Wet Laboratory Videos.

Journal of surgical education·2017

Same author

Extramedullary plasmacytoma of the lateral rectus muscle.

Orbit (Amsterdam, Netherlands)·2017

Same author

Dacryolithiasis: A Review.

Ophthalmic plastic and reconstructive surgery·2016

Same author

Surgeon point-of-view recording: Using a high-definition head-mounted video camera in the operating room.

Indian journal of ophthalmology·2015

Same author

Excision of periocular basal cell carcinoma with stereoscopic microdissection of surgical margins for frozen-section control: report of 200 cases.

Archives of ophthalmology (Chicago, Ill. : 1960)·2009

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Thyroid-related orbitopathy: concepts and management.

Robert C Della Rocca¹

¹Department of Ophthalmology, St. Luke's Roosevelt Hospital Center, New York, NY, USA.

Facial Plastic Surgery : FPS

|August 11, 2007

Summary

Thyroid-related orbitopathy, linked to thyroid dysfunction, impacts orbital tissues causing varied symptoms. Effective management requires prompt medical and surgical treatment for optimal outcomes.

Area of Science:

Ophthalmology
Endocrinology

Background:

Thyroid-related orbitopathy is a complex autoimmune disorder associated with systemic thyroid dysfunction.
It affects orbital and eyelid tissues, leading to a spectrum of clinical manifestations.

Purpose of the Study:

To summarize the understanding of thyroid-related orbitopathy.
To outline a systematic approach for managing this condition.

Main Methods:

Review of existing literature on thyroid-related orbitopathy.
Analysis of disease presentation, activity, and management strategies.

Main Results:

The disease can cause significant orbital and eyelid abnormalities, ranging from cosmetic issues to vision loss.
Management is challenging due to variable systemic thyroid disease activity.

More Related Videos

Three-Dimensional Reconstruction of Orbital Fractures

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

Related Experiment Videos

Last Updated: Jul 13, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Three-Dimensional Reconstruction of Orbital Fractures

Three-Dimensional Reconstruction of Orbital Fractures

Published on: May 16, 2025

Conclusions:

Successful management of thyroid-related orbitopathy necessitates a coordinated approach involving timely medical and surgical interventions.
Addressing both systemic thyroid disease and local orbital manifestations is crucial for improving patient outcomes.